Inventor
Li Zhao
Inventor
San Diego, CA, US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds27%
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%
C40BCombinatorial chemistry5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
H04LTransmission of digital information, e.g. telegraphic communication5%
H04WWireless communication networks5%
A01NPreservation of bodies of humans or animals or plants or parts thereof2%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
11,050,619Dynamic suspension of network operations by root for improved power outage recovery in low power and lossy network202111,032,836Method and device for BWP allocation202111,023,397System and method for monitoring per virtual machine I/O202110,799,504Heterocyclic compounds and uses as anticancer agents202010,620,188Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways202010,596,174Pyrrolopyrimidine compounds as inhibitors of protein kinases202010,562,918Heterocyclic compounds and uses thereof202010,449,196EGFR modulators and uses thereof201910,215,748Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways20199,920,074'Heterocyclic compounds and uses thereof'20189,845,295Triphenylethylene compounds and uses thereof20179,763,949'EGFR modulators and uses thereof'20179,623,027'EGFR modulators and uses thereof'20179,586,965'Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases'20179,550,792'Polycyclic substituted pyrazole kinase activity inhibitors and use thereof'20179,464,089'Heterocyclic compounds and uses thereof'20169,034,885'EGFR modulators and uses thereof'20158,685,988'EGFR modulators and uses thereof'2014Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2014–2020Patents assigned to ACEA BIOSCIENCES INC (12)· patent assignee history
2014–2020Based in San Diego, CA, US· patent location history
2017Based in Xuzhou, CN· patent location history
2019–2020Patents assigned to ACEA THERAPEUTICS INC (4)· patent assignee history
2019Patents assigned to ABASSI YAMA A (1)· patent assignee history
2021Patents assigned to ALIBABA GROUP HOLDING LTD (1)· patent assignee history
2021Patents assigned to CHINA ACADEMY TELECOMMUNICATIONS TECHNOLOGY (1)· patent assignee history
2021Based in Shanghai, CN· patent location history
2021Based in Beijing, CN· patent location history
2021Based in San Mateo, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ACEA BIOSCIENCES INC | 12 | 2014–2020 |
| ACEA THERAPEUTICS INC | 4 | 2019–2020 |
| ABASSI YAMA A | 1 | 2019 |
| ALIBABA GROUP HOLDING LTD | 1 | 2021 |
| CHINA ACADEMY TELECOMMUNICATIONS TECHNOLOGY | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 13 | 2014–2020 |
| Shanghai, CN | 1 | 2021 |
| Beijing, CN | 1 | 2021 |
| San Mateo, California, US | 1 | 2021 |
| Xuzhou, CN | 1 | 2017 |